All News

The American Academy of Neurology recently issued a guideline on oral and topical treatments for painful diabetic neuropathy. Here, a concise summary for clinicians.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Funds will be used to develop institutional and community programs that target high stress health care work environments, already strained before the pandemic.

Americans with anxiety, depression, and PTSD would be willing to try ketamine, psilocybin, and MDMA if they worked better than traditional medications, a Harris Poll finds.

Updated state maps released today by the CDC show physical inactivity in the US differs by state, region, race, and ethnicity.

Glucose and insulin levels decreased after just 3 minutes of the moderate-intensity exercise, a promising finding for those with type 2 diabetes, say authors of a new study.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Coronary heart disease prevalence in the US between 2011 and 2018 saw a statistically insignificant change, from 6.2% to 6.0%, respectively.

Findings highlight the importance of educating the public about the potential for nocebo responses to help reduce worries about COVID-19 vaccination.

The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Use of continuous glucose monitoring to assess time in target glucose range in T2D patients was evaluated in a systematic literature review covering ~14 000 participants.

California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.

Available therapies combined with new approaches that address social determinants of health and other barriers to care can help, suggests new statement.

VIDEO Interview: The COVID-19 pandemic has closed what discussion remained about the status of obesity as a disease, according to obesity expert Donna Ryan, MD.

WATCH: The FDA approval of semaglutide 2.4 mg for adults with obesity was "by far the big event in 2021," said Donna Ryan, MD. More from our look back/look ahead interview, here.

Using Mendelian randomization, a new study found in particular that waist-hip ratio may be a more important predictor of hospitalization than BMI.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.